Fig. 1

Data collection and sensor setup. a Individuals with PD underwent multiple clinical assessments spaced by 30 min during a first visit (day 1); assessments were done before and after each participant took their PD medication. A single follow-up assessment was performed about 2 weeks later during a second visit (day 2). During each assessment, participants performed a series of daily activities and standardized clinical tasks. b Overview of the MC10 BioStampRC senor; c Position of sensors on the body and sensor modalities; sensors were placed on both sides, although only one side is shown for clarity. Data were recorded from the accelerometer (acc) and gyroscope (gyro) sensors, or from the accelerometer and electromyography (EMG) sensor. Data from the EMG sensor was not used in the current study